IN-VITRO DIAGNOSTIC

DIAGNOSTIC RAPID TEST

The rapid diagnosis of metabolic diseases is an enormous opportunity for the patients and is one of the major medical tasks of today.

The life of patients can be decisively influenced and the outbreak of diseases can be prevented by early diagnosis. This is what our Lateralflow rapid tests stand for.

Our products are CE-compliant and are produced strictly according to the quality standard DIN ISO 13485:2016.

DETECTION OF METABOLIC DISORDERS

Increased levels of intact proinsulin in the blood are a highly specific indicator of a massive disorder of pancreatic insulin-producing cells (ß-cell dysfunction) and clinically relevant insulin resistance.

Non-alcoholic fatty liver is considered a hepatic manifestation of metabolic syndrome and NAFL is often associated with insulin resistance, which in turn promotes the progression of fatty liver disease.

IVD PRODUCT-OFFER

You can directly order our products via our shop system for medical professionals.

If you are looking for more details relating to one of our products, please visit our FAQ section for further information.

Our sales team will provide you with professional advice. Just write or call us. We would be happy to assist you.

Pharmact GmbH
International Distribution Headquarter
Telefon:   +49 (0) 621-1806178-0
Telefax:    +49 (0) 621-1806178-9
Kontakt:  sales@pharmact.de

BelFIBRO® - Rapid hepatic status diagnosis (F0-F4)

BelCARDIO® - Did a Myocardial infarction?

BelDIA PRE® - Screening for Type 2 Diabetes